Article info
Short report
Is first trimester exposure to the combination of antiretroviral therapy and folate antagonists a risk factor for congenital abnormalities?
- Dr Graham P Taylor, Department of Genitourinary Medicine and Communicable Diseases, Faculty of Medicine, Imperial College, Norfolk Place, London W2 1PG, UK g.p.taylor{at}ic.ac.uk
Citation
Is first trimester exposure to the combination of antiretroviral therapy and folate antagonists a risk factor for congenital abnormalities?
Publication history
- Accepted August 17, 2001
- First published December 1, 2001.
Online issue publication
December 01, 2001
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2001 Sexually Transmitted Infections